Inmar Supply Chain Solutions, LLC recalls All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.
Recalled August 30, 2023 · FDA recall D-1104-2023 · Inmar Supply Chain Solutions
Hazard
CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling. · FDA Class II
Units
Unknown
Sold at
Separate Distribution List (salvage buyers) provided by Inmar and will be uploaded. Final customer distribution unknown.
Description
CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.
Product
All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.
Manufacturer(s)
Inmar Supply Chain Solutions, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →